2m 2m 2m 2m 2m 2m 2m
TARSUS PHARMA (TARS)
NASDAQ
$72.76+$0.06 (+0.08%)
Price as of Aug 21, 2026 7:30 PM EDT- $3.2BMarket Cap
- 26.99%1-Year Change
- BiotechnologyIndustry
TARSUS PHARMA (TARS)
$72.76+$0.06 (+0.08%)
TARS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $72.70 | ||
Change | +$1.21 (+1.69%) | ||
Open | $71.72 | ||
High | $73.14 | ||
Low | $71.26 | ||
Previous Close | $71.49 | ||
Volume | 636,335 | ||
30-Day Average Volume | 755,392 | ||
1-Week Change | 5.06% | ||
1-Month Change | 26.96% | ||
1-Year Change | 26.99% | ||
3-Year Change | 324.65% | ||
5-Year Change | 203.93% | ||
Fundamentals | |||
Shares Outstanding | 43.9M | ||
Total Assets | $611.1M | ||
Market Cap | $3.2B | ||
Enterprise Value | $3.1B | ||
Period: QTR TTM FY | |||
Revenue | $173.9M | ||
Net Income | -$18.6M | ||
Free Cash Flow | $57.2M | ||
EBIT | -$13.7M | ||
EBITDA | -$13.4M | ||
Net Working Capital | $386.2M | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | -228 | ||
Enterprise Value/Revenue | 18 | ||
P/B | 9 | ||
P/E | -169 | ||
PEG | 1 | ||
Price/Free Cash Flow | 56 | ||
Price/Operating Cash Flow | 52 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue